C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
C4 Therapeutics (Nasdaq: CCCC), a clinical-stage biopharmaceutical company focused on targeted protein degradation, will participate in the UBS Targeted Protein Degradation Day, held virtually on July 15, 2024. The company's management will engage in a fireside chat from 12:00 pm ET to 12:30 pm ET. A live webcast of the event will be accessible on the Investors section of C4 Therapeutics' website, with a replay available for 30 days post-event.
- None.
- None.
WATERTOWN, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in a fireside chat at the UBS Targeted Protein Degradation (TPD) Day taking place virtually on July 15, 2024.
Fireside Chat Details:
Event: UBS TPD Day
Date/Time: Monday, July 15, 2024 from 12:00 pm ET – 12:30 pm ET
A live webcast will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 30 days following the live event.
About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.
Contacts:
Investors:
Courtney Solberg
Senior Manager, Investor Relations
CSolberg@c4therapeutics.com
Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com
FAQ
When will C4 Therapeutics participate in the UBS Targeted Protein Degradation Day?
What time is the C4 Therapeutics fireside chat at the UBS TPD Day?
How can I watch the C4 Therapeutics fireside chat at the UBS Targeted Protein Degradation Day?
Will there be a replay available for the C4 Therapeutics fireside chat at the UBS TPD Day?
What is the focus of C4 Therapeutics' presentation at the UBS Targeted Protein Degradation Day?
